Antidepressant drugs modulate growth factors in cultured cells
Tóm tắt
Different classes of antidepressant drugs are used as a treatment for depression by activating the catecholinergic system. In addition, depression has been associated with decrease of growth factors, which causes insufficient axonal sprouting and reduced neuronal damage repair. In this study, antidepressant treatments are analyzed in a cell culture system, to study the modulation of growth factors. We quantified the transcription of several growth factors in three cell lines after application of antidepressant drugs by real time polymerase chain reaction. Antidepressant drugs counteracted against phorbolester-induced deregulation of growth factors in PMA-differentiated neuronal SY5Y cells. We also found indications in a pilot experiment that magnetic stimulation could possibly modify BDNF in the cell culture system. The antidepressant effects antidepressant drugs might be explained by selective modulation of growth factors, which subsequently affects neuronal plasticity.
Tài liệu tham khảo
Schildkraut JJ: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965, 122 (5): 509-522.
Kornhuber J, Retz W, Riederer P: Slow accumulation of psychotropic substances in the human brain. Relationship to therapeutic latency of neuroleptic and antidepressant drugs?. J Neural Transm Suppl. 1995, 46: 315-323.
Blier P, de Montigny C: Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 1994, 15 (7): 220-226. 10.1016/0165-6147(94)90315-8.
Carroll RC, Zukin RS: NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity. Trends Neurosci. 2002, 25 (11): 571-577. 10.1016/S0166-2236(02)02272-5.
Jaffe EH: Ca2+ dependency of serotonin and dopamine release from CNS slices of chronically isolated rats. Psychopharmacology (Berl). 1998, 139 (3): 255-260. 10.1007/s002130050713.
Burgi S, Baltensperger K, Honegger UE: Antidepressant-induced switch of beta 1-adrenoceptor trafficking as a mechanism for drug action. J Biol Chem. 2003, 278 (2): 1044-1052. 10.1074/jbc.M209972200.
Porras G, De Deurwaerdere P, Moison D, Spampinato U: Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum. Eur J Neurosci. 2003, 17 (4): 771-781. 10.1046/j.1460-9568.2003.02512.x.
Krieglstein K, Strelau J, Schober A, Sullivan A, Unsicker K: TGF-beta and the regulation of neuron survival and death. J Physiol Paris. 2002, 96 (1–2): 25-30. 10.1016/S0928-4257(01)00077-8.
Specht H, Peterziel H, Bajohrs M, Gerdes HH, Krieglstein K, Unsicker K: Transforming growth factor beta2 is released from PC12 cells via the regulated pathway of secretion. Mol Cell Neurosci. 2003, 22 (1): 75-86. 10.1016/S1044-7431(02)00023-4.
Barker AT, Jalinous R, Freeston IL: Non-invasive magnetic stimulation of human motor cortex. The Lancet. 1985, 1: 1106-1107. 10.1016/S0140-6736(85)92413-4.
Nahas Z, Kozel FA, Li X, Anderson B, George MS: Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003, 5 (1): 40-47. 10.1034/j.1399-5618.2003.00011.x.
Pascual-Leone A, Rubio B, Pallardo F, Catala MD: Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 1996, 348 (9022): 233-237. 10.1016/S0140-6736(96)01219-6.
Eranti S, Mogg A, Pluck G, Landau S, Purvis R, Brown RG, Howard R, Knapp M, Philpot M, Rabe-Hesketh S: A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry. 2007, 164 (1): 73-81. 10.1176/appi.ajp.164.1.73.
Lang UE, Bajbouj M, Gallinat J, Hellweg R: Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacology (Berl). 2006, 187 (1): 56-59. 10.1007/s00213-006-0399-y.
Renauld AE, Spengler RN: Tumor necrosis factor expressed by primary hippocampal neurons and SH-SY5Y cells is regulated by alpha(2)-adrenergic receptor activation. J Neurosci Res. 2002, 67 (2): 264-274. 10.1002/jnr.10101.
Sarkanen JR, Nykky J, Siikanen J, Selinummi J, Ylikomi T, Jalonen TO: Cholesterol supports the retinoic acid-induced synaptic vesicle formation in differentiating human SH-SY5Y neuroblastoma cells. J Neurochem. 2007, 102 (6): 1941-1952. 10.1111/j.1471-4159.2007.04676.x.
Vaidya VA, Siuciak JA, Du F, Duman RS: Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience. 1999, 89 (1): 157-166. 10.1016/S0306-4522(98)00289-9.
McEwen BS, Olie JP: Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol Psychiatry. 2005, 10 (6): 525-537. 10.1038/sj.mp.4001648.
Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry. 1997, 54 (7): 597-606.
Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T: Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ. 1984, 14 (2): 135-144. 10.1016/0045-6039(84)90038-1.
Duman RS, Vaidya VA: Molecular and cellular actions of chronic electroconvulsive seizures. J Ect. 1998, 14 (3): 181-193.
Alfonso J, Frasch AC, Flugge G: Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus. Rev Neurosci. 2005, 16 (1): 43-56.
Laifenfeld D, Klein E, Ben-Shachar D: Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms. J Neurochem. 2002, 83 (5): 1054-1064. 10.1046/j.1471-4159.2002.01215.x.
Groves JO: Is it time to reassess the BDNF hypothesis of depression?. Mol Psychiatry. 2007, 12 (12): 1079-1088. 10.1038/sj.mp.4002075.
Mallei A, Shi B, Mocchetti I: Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol Pharmacol. 2002, 61 (5): 1017-1024. 10.1124/mol.61.5.1017.
Nair A, Vadodaria KC, Banerjee SB, Benekareddy M, Dias BG, Duman RS, Vaidya VA: Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus. Neuropsychopharmacology. 2007, 32 (7): 1504-1519. 10.1038/sj.npp.1301276.
Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL, Mohammed A, Pham Q, Laeng P, Brockman JA: Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods. 2004, 138 (1–2): 173-188. 10.1016/j.jneumeth.2004.04.002.
Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, Bukhman YV, Young TA, Charles V, Palfreyman MG: Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci. 2004, 24 (11): 2667-2677. 10.1523/JNEUROSCI.5377-03.2004.
Maragnoli ME, Fumagalli F, Gennarelli M, Racagni G, Riva MA: Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol Psychiatry. 2004, 55 (11): 1095-1102. 10.1016/j.biopsych.2004.02.003.
Levkovitz Y, Grisaru N, Segal M: Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus. Neuropsychopharmacology. 2001, 24 (6): 608-616. 10.1016/S0893-133X(00)00244-X.
Yukimasa T, Yoshimura R, Tamagawa A, Uozumi T, Shinkai K, Ueda N, Tsuji S, Nakamura J: High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry. 2006, 39 (2): 52-59. 10.1055/s-2006-931542.
Zanardini R, Gazzoli A, Ventriglia M, Perez J, Bignotti S, Rossini PM, Gennarelli M, Bocchio-Chiavetto L: Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord. 2006, 91 (1): 83-86. 10.1016/j.jad.2005.12.029.
Henkel AW, Upmann I, Bartl CR, Bonsch D, Reichardt C, Maler JM, Nurnberger M, Umstatter R, Reulbach U, Kornhuber J: Light-induced exocytosis in cell development and differentiation. J Cell Biochem. 2006, 97 (6): 1393-1406. 10.1002/jcb.20751.
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65 (1–2): 55-63. 10.1016/0022-1759(83)90303-4.